Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials

We assessed whether oral insulin slowed metabolic decline after 1 year of treatment in individuals at high risk for type 1 diabetes. Two oral insulin trials that did not show efficacy overall and had type 1 diabetes as the primary end point were analyzed: the Diabetes Prevention Trial–Type 1 (DPT-1)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetes
Egile Nagusiak: Sosenko, Jay M., Skyler, Jay S., Herold, Kevan C., Schatz, Desmond A., Haller, Michael J., Pugliese, Alberto, Cleves, Mario, Geyer, Susan, Rafkin, Lisa E., Matheson, Della, Palmer, Jerry P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Diabetes Association 2020
Gaiak:
Pharmacology and Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372067/
https://ncbi.nlm.nih.gov/pubmed/32439823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db20-0166
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak